SEC EDGAR: 8-K filingsUnited States10 November 2026
8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)
This is an official announcement record
Firsthand records what SEC EDGAR: 8-K filings announced and links to the original. The wording below is theirs, not ours.
Filed: 2026-11-10 AccNo: 0001193125-26-455640 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.02: Results of Operations and Financial Condition Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or
Read the official announcement
Opens www.sec.gov
More from SEC EDGAR: 8-K filings
- 8-K - Spero Therapeutics, Inc. (0001701108) (Filer)10 November 2026
- 8-K - Aptera Motors Corp (0001786471) (Filer)10 November 2026
- 8-K - Star Equity Holdings, Inc. (0001210708) (Filer)10 November 2026
- 8-K - Sunrise Realty Trust, Inc. (0002012706) (Filer)10 November 2026
- 8-K - ASHFORD HOSPITALITY TRUST INC (0001232582) (Filer)10 November 2026
This content is for informational purposes only and is not financial, investment, tax, or legal advice. Rates, fees, and terms change and may differ from what is shown here; verify current details with the provider before acting. Consider consulting a qualified financial professional about your specific situation.